Business · 12/03/2001Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Postmarketing Safety Reporting for Human Drugs and Vaccines
Summary
The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies comply with postmarketing safety reporting requirements for human drugs and vaccines.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →